CAS 123441-03-2
:Rivastigmine
Description:
Rivastigmine is a reversible inhibitor of the enzyme acetylcholinesterase, primarily used in the treatment of Alzheimer's disease and Parkinson's disease dementia. It enhances cholinergic neurotransmission by preventing the breakdown of acetylcholine, a neurotransmitter crucial for memory and learning. Rivastigmine is characterized by its chemical formula, which includes elements such as carbon, hydrogen, nitrogen, and oxygen, reflecting its complex structure. The substance is typically administered in the form of capsules or transdermal patches, allowing for flexible dosing and improved patient compliance. Its pharmacokinetics indicate that it is absorbed relatively quickly, with peak plasma concentrations occurring within a few hours after administration. Rivastigmine is known for its side effects, which may include nausea, vomiting, diarrhea, and insomnia, necessitating careful monitoring of patients. Additionally, it has a relatively short half-life, requiring multiple daily doses or continuous delivery via patches to maintain therapeutic levels. Overall, Rivastigmine plays a significant role in managing cognitive symptoms associated with neurodegenerative diseases.
Formula:C14H22N2O2
InChI:InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1
InChI key:InChIKey=XSVMFMHYUFZWBK-NSHDSACASA-N
SMILES:O(C(N(CC)C)=O)C1=CC([C@@H](N(C)C)C)=CC=C1
Synonyms:- 3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl-N-methylcarbamate
- 3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate
- 3-[1-(Dimethylamino)Ethyl]Phenyl Ethyl(Methyl)Carbamate
- Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester
- Carbamic acid, ethylmethyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester
- Carbamic acid, ethylmethyl-, 3-[1-(dimethylamino)ethyl]phenyl ester, (S)-
- ENA 713 free base
- Ethylmethylcarbamic acid 3-((1S)-1-(dimethylamino)ethyl)phenyl ester
- Exelon
- Nimvastid
- Prometax
- Rivastach
- Rivastigimine(Forr&Donly)
- Rivastigmine Base
- S-Rivastigmine
- Sdz 212-713
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 13 products.
Rivastigmine L-Tartrate
CAS:Formula:C14H22N2O2·C4H6O6Purity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:400.43Rivastigmine
CAS:Formula:C14H22N2O2Purity:>98.0%(HPLC)Color and Shape:Colorless to Light yellow clear liquidMolecular weight:250.34Rivastigmine
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C14H22N2O2Color and Shape:Yellow Clear Liquid ViscousMolecular weight:250.16813Rivastigmine
CAS:<p>Rivastigmine (Exelon) is a Cholinesterase Inhibitor, used for therapy of Alzheimer disease.</p>Formula:C14H22N2O2Purity:99.45%Color and Shape:SolidMolecular weight:250.343-[(1S)-1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate
CAS:Formula:C14H22N2O2Purity:98%Color and Shape:LiquidMolecular weight:250.3367Rivastigmine
CAS:Formula:C14H22N2O2Purity:≥ 98.0%Color and Shape:Colourless to light-yellow liquidMolecular weight:250.34Rivastigmine
CAS:Controlled ProductFormula:C14H22N2O2Color and Shape:ColourlessMolecular weight:250.34(S)-Rivastigmine-d4
CAS:Controlled Product<p>Applications Rivastigmine-d4 is an intermediate in the synthesis of Rivastigmine-d4 Tartrate Salt (R541004), the labeled analogue of Rivastigmine Tartrate Salt (R541000), a brain selective acetylcholinesterase inhibitor. Nootropic.<br>References Rosler, M., et al.: Brit. Med. J., 318, 633 (1999), Enz, A., et al.: Prog. Brain Res., 98, 431 (1993),<br></p>Formula:C14H18D4N2O2Color and Shape:ColourlessMolecular weight:254.36Rivastigmine
CAS:Controlled Product<p>Acetylcholinesterase and butyrylcholinesterase inhibitor</p>Formula:C14H22N2O2Purity:Min. 95%Color and Shape:PowderMolecular weight:250.34 g/mol(S)-Rivastigmine
CAS:<p>Applications S-Rivastigmine is an isomer of Rivastigmine ( an acetylcholinesterase inhibitor used in the treatment of neurological disorders such as Alzheimer’s disease.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Howes, L et al.: Drug. Safe., 37, 391 (2014); Shahar, O. et al.: Nucl. Acids Res., 42, 5869 (2014);<br></p>Formula:C14H22N2O2Color and Shape:ColourlessMolecular weight:250.34










